High USP9X gene expression was associated before with shorter survival of patients with follicular lymphoma, esophageal squamous cell carcinoma, non-small cell lung cancer, and osteosarcoma [22,47,48,49], but not with the survival of patients with prostate cancer. Here, USP9X is linked to non-small cell lung carcinoma.